Reuters: Health
Japan's biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment.
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
Reuters: Health
Japan's biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment.
Reuters: Health
Japan's biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment